Skip to content

Percutaneous Cryoablation of Intercostal Nerves for the Treatment of Rib Fractures

Percutaneous Cryoablation of Intercostal Nerves for the Treatment of Rib Fractures

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06533904
Enrollment
30
Registered
2024-08-01
Start date
2026-09-01
Completion date
2028-07-01
Last updated
2026-02-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chest Wall Disorder, Pain, Chest, Respiratory Distress Syndrome, Respiratory Failure, Respiratory Insufficiency, Rib Fracture Multiple, Rib Fractures, Rib Trauma, Trauma

Keywords

Trauma, Respiratory Failure, Respiratory Distress, Respiratory Insufficiency, Rib Fractures, Chest Wall Trauma, Percutaneous Cryoablation, Multimodal Pain Therapy, Multimodal Pain Regimen

Brief summary

The goal of this double blinded randomized control trial is to learn if percutaneous cryoablation of traumatic rib fractures improves outcomes. The main questions it aims to answer are: Does percutaneous cryoablation improve short and long term pain scores? Does percutaneous cryoablation improve short and long term respiratory mechanics? Does percutaneous cryoablation improve long term quality of life? Does percutaneous cryoablation decrease delirium? Researchers will compare cryoablation to standard multimodal pain therapy to see if this impacts respiratory recovery. Participants will undergo randomization, percutaneous cryoablative procedure, and participate in tests at pre-determined intervals to evaluate their pulmonary recovery.

Interventions

PROCEDUREPercutaneous Cryoablation of Intercostal Nerves

Percutaneous Cryoablation of Intercostal Nerves

OTHERMulti-modal pain regimen

Standard rib fracture protocol including cyclooxygenase inhibitors, anti-neuropathic, muscle relaxers, short term anesthesia interventions (percutaneous block, epidural)

Sponsors

Loma Linda University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Intervention model description

Patients will be randomized to standard multi-modal pain regimen with percutaneous cryoablation versus standard multi-modal pain regimen alone.

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* \> 18 years old * \> 2 rib fractures * Verbal Pain score \> 5 * Incentive Spirometry \< 60% of predicted

Exclusion criteria

* Isolated Fractures of Ribs 1-3 and/or 10-12 * Posterior Rib Fracture \< 4 cm from costovertebral joint * Sternal, Clavicle, Scapula Fracture * Thoracic Spinal Fracture of any type * Open Abdominothoracic Surgery * Unstable Spine * Extensive Subcutaneous Emphysema * BMI \> 35 * Plan for Rib Plating * Chronic Opioid Use * Prior to study enrollment: Intubated, Traumatic Brain Injury, Dementia, Cognitive Impairment, Encephalopathy * Coagulopathy, Shock at time of ablation * Inability to participate in activities of daily living prior to injury * Home O2 use prior to trauma * Inhalation Injury * Rib Fractures due to cardiopulmonary resuscitation * Life Expectancy \< 6 months * \> 48 hours from injury * Pregnant, Incarcerated

Design outcomes

Primary

MeasureTime frameDescription
Pain Score: Numeric Pain ScaleThrough study completion, up to 1 yearShort and Long Term Pain Scores. Range from 0 to 10 where 0 is no pain and 10 is most severe and worse outcome.
Rate of abnormal respiratory mechanics: Incentive SpirometryThrough study completion, up to 1 year
Rate of abnormal respiratory mechanics: Pulmonary Function TestsThrough study completion, up to 1 yearShort and Long Term Respiratory Mechanics. Pulmonary Function Tests will specifically measure Forced Expiratory Volume in 1 second (FEV1) and Forced Vital Capacity (FVC)
Rate of delirium: Confusion Assessment Method (CAM) ScoreThrough study completion, up to 1 yearThe score ranges from 0 to 19. Where higher scores indicate more severe delirium and low scores indicate less severe or no delirium
Quality of Life on SurveyThrough study completion, up to 1 yearLong Term Quality of Life

Secondary

MeasureTime frameDescription
Rate of PneumoniaThrough study completion, up to 1 year
Rate of need for Intubation/Mechanical VentilationThrough study completion, up to 1 year
Rate of need for tracheostomyThrough study completion, up to 1 year
Number of Ventilatory DaysThrough study completion, up to 1 year
ICU Length of StayThrough study completion, up to 1 year
Hospital Length of StayThrough study completion, up to 1 year
Acute Respiratory Distress SyndromeThrough study completion, up to 1 year
Rate of MortalityThrough study completion, up to 1 year
Rate of Pleural Space ComplicationsThrough study completion, up to 1 yearHemothorax, Delayed hemothorax, Pneumothorax, Empyema, Hydrothorax, Rate of tube thoracostomy

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026